L

Lexeo Therapeutics Inc
NASDAQ:LXEO

Watchlist Manager
Lexeo Therapeutics Inc
NASDAQ:LXEO
Watchlist
Price: 6.53 USD -0.76%
Market Cap: 215.9m USD
Have any thoughts about
Lexeo Therapeutics Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-1.6
Current
-5.2
Median
6.2
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-1.6
=
Enterprise Value
97.4m USD
/
Operating Cash Flow
-59.5m USD
All Countries
Close
 
US
L
Lexeo Therapeutics Inc
NASDAQ:LXEO
Average EV/OCF: 21.9
Negative Multiple: -1.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -240 863.6
US
Abbvie Inc
NYSE:ABBV
22.1
US
Amgen Inc
NASDAQ:AMGN
25.9
US
Gilead Sciences Inc
NASDAQ:GILD
11
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -114
US
E
Epizyme Inc
F:EPE
Negative Multiple: -467.5
AU
CSL Ltd
ASX:CSL
33.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.1
NL
argenx SE
XBRU:ARGX
Negative Multiple: -131.1

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A